In order for Merck to re-sell Polymer Factory SpheriCal® products, a Quality Agreement exists between the parties covering the distributed products. The extension of the agreement means that Merck can now repurchase more of Polymer Factory SpheriCal® products. Several of the products are currently available for purchase at Merck.

The relationship with re-sellers and distributors means that Polymer Factory’s products gets increased visibility. Merck KGaA is one of the world’s largest chemical and pharmaceutical companies.

CTO Michael Malkoch comments:

“The extension of this quality agreement will allow Merck to continue providing state-of-the-art SpheriCal® calibrants for its customers, ranging from universities and research institutes to research intensive biotech and big-pharma corporates. Their international presence and sales outreach offer a great platform for showcasing of Polymer Factory’s products.”

About Polymer Factory

Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.

For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com

Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.